The section of Oncology at the Cornell College of Veterinary Medicine needs cats for a clinical trial on injection-site sarcomas (also known as a fibrosarcoma), a tumor that can arise following injections. Although the cause is unknown, treatments are available, such as the anti-cancer drug carboplatin. The study wants t0 determine if customized doses based on kidney function rather than body weight will be effective. Eligible cats must have a tumor greater than 2 cm in diameter with confirmation of tumor type from histology (incisional biopsy). The tumor may be a primary tumor or metastatic lesion.Email vet-research@cornell.edu if you’re interested.
